Strong Membership Growth
Health plan membership of 284,800 representing ~31% year-over-year growth, driving scale and supporting revenue expansion.
Revenue Expansion
Total revenue of $1.2 billion in Q1, up 33% year-over-year.
Margin and Profitability Improvement
Adjusted EBITDA of $38 million, up 88% year-over-year, implying an adjusted EBITDA margin of 3.1% and ~90 basis points of margin expansion versus prior year.
Adjusted Gross Profit and Medical Benefit Ratio (MBR)
Adjusted gross profit of $146 million with an adjusted MBR of 88.2%, an improvement of ~20 basis points year-over-year.
Operating Efficiency (SG&A)
Adjusted SG&A of $108 million (up 24% year-over-year in absolute dollars) but improved as a percentage of revenue to 8.7% from 9.4% (~60 basis points improvement), reflecting automation and scaling benefits.
Balance Sheet and Liquidity
Strong liquidity with $726 million in cash, cash equivalents and short-term investments; funded leverage improved to 2.6x trailing 12-month EBITDA.
Raised Full-Year Guidance and Confident Outlook
Full-year 2026 guidance raised: membership expected 294,000–299,000; revenue guidance $5.16B–$5.21B (midpoint implies ~31% YoY growth); adjusted gross profit and adjusted EBITDA low-ends each increased by $5M, and management expects ~60% of full-year EBITDA in H1 (vs ~55% prior-year).
Operational Execution and Technology Progress
Claims auto-adjudication improved from under 15% a year ago to over 60% year-to-date; active investments in claims automation, AI-enabled contract management and risk stratification, and continued capex (~$40M expected) for software and AI to drive future SG&A and MLR improvements.
Clinical Performance and Part D Trends
Clinical teams helped keep inpatient admissions largely within expected ranges after a one-time workflow issue; Part D ran modestly favorable through the first three months and was described as tracking well in Q1.